Hyderabad & New Delhi, India, June 12, 2015: Mapmygenome India launched a new genetic test SlimGene™ for weight loss on June 12, 2015. With this service, weight watchers can get insights into their genetic predisposition to appetite, fat storage and absorption, and body mass index (BMI). Nutritionists and dieticians can recommend diet changes to their clients using the inferences from this test. Mapmygenome has already started collaborating with nutritionists and nutrition clinics and many such partnerships will be announced soon.
Ms. Anu Acharya, CEO of Mapmygenome, said, “Your genes need not define your jeans. When you know what the genes say, you can easily take charge of other controlling factors to achieve your ideal weight.”
SlimGene is a non-invasive genetic test that predicts your predisposition to appetite, fat storage and absorption, and body mass index (BMI) from your saliva or blood. Particular set of instructions related to metabolism, excess fat transport and storage, brain signalling, and energy conversion are assessed by studying specific DNA variants at key locations. Using this information, nutritionists can prescribe the best diet to achieve ideal weight, improve metabolism, regulate diet habits, and prevent diseases.
SlimGene also comes with easy upgrade options to include diet and fitness genetics or nutrition and genetic counselling. Price starts at INR 2000. Learn more about SlimGene from Mapmygenome store: http://mapmygenome.in/personal-genomics/slimgene
Mapmygenome India offers a variety of services in the domains of personal genomics, molecular diagnostics, DNA forensics, and brain wellness. Their products and services can be purchased from their stores online (www.mapmygenome.in), through their e-commerce partners such as amazon.in, or from their wide network of diagnostics and hospital partners.
As pioneers of personal genomics in India, they created a new market in for predictive tests with their flagship brand Genomepatri™ in April 2013. In February 2014, the Government of Karnataka awarded them the Bio Excellence award “Emerging Company of the Year”. In March 2015, they raised a US $ 1.1 million Pre Series A rounding of funding from multiple sources.
Personal genomics products provide insights into the genetic basis of health, including traits, lifestyle, drug responses, inherited conditions, and diseases. By combining genetic report and health history with genetic counseling, Mapmygenome provides actionable steps for individuals and their physicians towards a healthier life. Molecular diagnostics are tests recommended by doctors for cancer, cardiovascular, neuromuscular, and other key conditions. Mapmygenome also offers molecular tests for TB that increase accuracy at very low costs. DNA Forensics include maternity, paternity, sibling, and other identification tests. Brain wellness include assessments for improving emotional and cognitive efficacy, assessing leadership skills, etc.